Financials

  • Market Capitalization 36.3476 M
  • Employee 89
  • Founded 2012
  • CEO N/A
  • Website www.omniab.com
  • Headquarter Delaware, United States
  • FIGI BBG012QXTPF0
  • Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.21
売上高対価格比率
0.24

Related tickers

#名前価格24時間%7日%1か月%1年%時価総額過去7日
4372
ALGS
Aligos Therapeutics, Inc. - Common stock
5.80 USD-1.02%-17.26%+35.20%-40.76%36.17 M USD
4374
ACTU
Actuate Therapeutics, Inc. - Common stock
1.50 USD-1.32%+21.95%+31.58%-63.24%36.02 M USD
4382
CNTX
Context Therapeutics Inc. - Common Stock
0.37 USD-5.13%-19.57%-40.32%-56.47%34.00 M USD
4386
RNAZ
TransCode Therapeutics, Inc. - Common Stock
2.30 USD+9.52%-15.44%-49.12%-75.81%38.94 M USD